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Abstract
Formate is a precursor for the de novo synthesis of purine and deoxythymidine nucleotides. Formate also interacts
with energy metabolism by promoting the synthesis of adenine nucleotides. Here we use theoretical modelling
together with metabolomics analysis to investigate the link between formate, nucleotide and energy metabolism. We
uncover that endogenous or exogenous formate induces a metabolic switch from low to high adenine nucleotide
levels, increasing the rate of glycolysis and repressing the AMPK activity. Formate also induces an increase in the
pyrimidine precursor orotate and the urea cycle intermediate argininosuccinate, in agreement with the ATP-
dependent activities of carbamoyl-phosphate and argininosuccinate synthetase. In vivo data for mouse and human
cancers confirms the association between increased formate production, nucleotide and energy metabolism. Finally,
the in vitro observations are recapitulated in mice following and intraperitoneal injection of formate. We conclude that
formate is a potent regulator of purine, pyrimidine and energy metabolism.
Introduction
Formate is a precursor of nucleotide synthesis and a
potential growth-limiting factor1,2. Mammalian cells
produce formate at rates exceeding the biosynthetic
demand and excess formate is released from cells (for-
mate overflow)3,4. Cells produce formate from the oxi-
dation of the third carbon of serine using either a cytosolic
or mitochondrial pathway1,2. Both pathways can sustain
the one-carbon demands of cell proliferation, but the
mitochondrial pathway is essential for formate overflow4–6.
We have also shown that the catabolism of serine to
formate is increased in tumours of genetically engineered
mouse models of cancer resulting in an increase of serum
formate levels7. Yet we do not understand what is the
selective advantage of excess formate production by
mitochondrial serine catabolism.
Mitochondrial serine hydromethyltransferase (SHMT2)
provides methyl groups for the synthesis of taur-
inomethyluridine, which in turn is required for efficient
mitochondrial protein synthesis8. Mitochondrial formate
production also contributes to maintain low levels of
cytosolic tetrahydrofolate9. Tetrahydrofolate is prone to
oxidative damage and breakdown leading to the formation
of toxic products9,10. In contrast, other folate species, such
as 10-formyl-tetrahydrofolate, are more stable. Synthesis
of 10-formyl-tetrahydrofolate from tetrahydrofolate and
formate protects the cytosolic tetrahydrofolate pool from
oxidative damage. However, there is no evidence that
taurinomethyluridine synthesis or the protection of the
tetrahydrofolate pool imply a one-carbon units demand
comparable to the rate of mitochondrial serine catabolism
to formate.
We hypothesize that formate overflow is associated with
the highest metabolic demand of one-carbon units: purine
synthesis. This hypothesis is counterintuitive because
© The Author(s) 2020
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Alexei Vazquez (alexei.vazquezvazquez@glasgow.ac.uk)
1Cancer Research UK Beatson Institute, Glasgow, UK
2Center of Molecular Immunology, Havana, Cuba
Full list of author information is available at the end of the article
These authors contributed equally: Kristell Oizel, Jacqueline Tait-Mulder
Edited by G. Melino


































formate overflow is itself defined by excess formate pro-
duction beyond the biosynthetic demand. However, the
linear relationship implied by mass conservation (one-
carbon produced= one-carbon consumed), needs to be
put in the context of the non-linear kinetic relationships
between metabolic rates and metabolite concentrations.
In other words, we also hypothesize that formate overflow
is rooted in a non-linear effect of enzyme kinetics. Here
we provide evidence in support of this hypothesis.
Materials and methods
Chemicals
All cell culture material was obtained from Life Tech-
nologies and all the chemicals used were from Sigma-
Aldrich unless stated otherwise.
Cell lines and cultures
HAP1 cells were obtained from KJ Patel’s laboratory in
the University of Cambridge. Cells were cultured in
IMDM medium supplemented with 10% FBS and kept at
37 °C with 5% CO2. Cell counts and volumes were
assessed using the Casy Technology (Innovatis). For
Seahorse experiments, cells were mixed with Trypan Blue
(50/50) and counted using the Countess optics and image
automated cell counter (Life Technologies).
A lentiviral plasmid encoding SHMT2 CRISPR guide
RNA was generated by cloning primers containing a
SHMT2 guide RNA sequence5 into the lentiviral vector
lentiCRISPR v2, a gift from Feng Zhang (Addgene
plasmid # 52961; http://n2t.net/addgene:52961; RRID:
Addgene_52961)11. HEK293T cells were transfected
with above lentiCRISPR SHMT2 plasmid or control V2
plasmid together with helper plasmids pPAX2 and
UVSVG (Addgene #8454 and #12260) using Lipofecta-
mine 2000 (Life Technologies). Viral supernatant was
harvested, filtered and incubated for 24 h on recipient
cells lines (HCT116, MDA-MB-231, SKB3, T47D and
MDA-MB-468) two consecutive times in the presence of
6 µg/µl polybrene (Sigma-Aldrich). Cells were selected for
10 days with 2 µg/µl puromycin (Sigma-Aldrich) to obtain
a stable polyclonal population and knockout of SHMT2
expression was verified by western blot using a SHMT2
antibody (#12762) (Cell Signalling Technologies). All cells
were cultured in in DMEM supplemented with 10% FBS
and glutamine. SHMT2 deficient cells were cultured in
the presence of HT supplement (Life Technologies).
In vivo work
In vivo experiments were carried out in dedicated bar-
riered facilities proactive in environmental enrichment
under the EU Directive 2010 and Animal (Scientific
Procedures) Act (HO licence numbers: 70/8645, 70/8468)
with ethical review approval (University of Glasgow).
Animals were cared for by trained and licensed
individuals and humanely sacrificed using Schedule 1
methods. MMTV-PyMT (females) and APCmin (males &
females) mice as previously described7. Wild-type female
C57BL/6J mice (8 weeks) were purchased from
Charles River.
In the formate bolus experiment, mice were randomized
in individual groups (different time points and treatment
arms). Mice were sacrificed at respective time points.
Blood was immediately taken by cardiac puncture,
transferred into Eppendorf tubes and centrifuged at 4 °C
for 10min at 13k G. The supernatant was transferred into
new Eppendorf tubes and flash frozen in liquid nitrogen.
Tissues were harvested in Eppendorf tubes and flash
frozen in liquid nitrogen. Flash frozen tissue samples were
blinded with random IDs and processed by a different
person for metabolite extraction and analysis. After final
data analysis IDs were uncovered. All tissues were pro-
cessed frozen on dry ice. From each tissue 5–20mg were
balanced and transferred into Precellys CK14 tubes
(Bertin Technologies, Montigny-le-Bretonnex, France).
Tissues were dissolved in 20 mg/ml extraction solvent
(Acetonitrile/MeOH/H2O (30/50/20)) and homogenized
in a cooled Precellys 24 (Bertin Technologies, Montigny-
le-Bretonnex, France) with 3 × 20 s at 7200 rpm and a 20-s
break. Lysed tissue samples were transferred into
Eppendorf tubes and centrifuged for 10min at 4 °C.
Supernatant was transferred into LC-MS vials for mass
spec analysis.
Intracellular formate quantification
HAP1 WT or SHMT2 KO cells were seeded in 6-well
plates and stimulated with 1 mM formate (Sigma-
Aldrich), for 24 h. One plate was used for counting, while
cells in other plate were washed twice in ice-cold PBS and
lysed in formate assay buffer at a ratio of 1,000,000 cells
per 100 μl buffer. Lysates were transferred into Eppendorf
tubes and centrifuged for 10min at 14,000 rpm. Formate
concentrations in supernatants were measured using a
formate standard as a standard curve. Further proceedings
were performed according to manufacters’ protocol of the
Formate Assay Kit (Abcam, ab111748). In brief, formate
assay buffer, enzyme mix, substrate mix were added to
each standard and test sample in 96-well plates and
incubated for 60 min at 37 °C. During the reaction, for-
mate is oxidized to generate a product resulting in colour
formation (λ= 450 nm) proportional to formate con-
centration. Readings were measured at OD450nm in a
microplate reader.
Metabolite quantification
Metabolite extraction and analysis was performed as
previously described12. Briefly, cells were washed with
PBS once and extracted with ice-cold extraction solvent
(Acetonitrile/MeOH/H2O (30/50/20)), shaken for 5 min
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at 4 °C, transferred into Eppendorf tubes and centrifuged
for 5 min at 18k G. The supernatant was transferred to
LC-MS glass vials and kept at −80 °C until measurement.
LC-MS analysis was performed as described previously
using pHILIC chromatography and a Q-Exactive mass
spectrometer (Thermo Fisher Scientific). Raw data ana-
lysis was performed using TraceFinder (Thermo Fisher
Scientific) software. Peak areas were normalized to cell
volume. Estimation of exchange rates and proliferation
rates was done as described previously4.
Protein, sample preparation
Cells were harvested by trypsinization, the pellet was
washed twice in cold PBS then lyzed in 6M Guanidinium
HCL heated solution. Samples were boiled at 99 °C for
10min then sonicated. Protein quantification was made
using Bradford solution. Proteins were reduced with 10mM
DTT, for 30min at 54 °C, and subsequently alkylated with
55mM Iodoacetamide for 1 h at room temperature. Alky-
lated proteins were then submitted to a two-step digestion.
First using Endoproteinase Lys-C (Alpha Laboratories) for
1 h at 35 °C, after which partial digests were further diges-
ted, with trypsin (Promega) overnight at 35 °C.
Protein, MS analysis
Digested peptides were desalted using StageTip13 and
separated on a nanoscale C18 reverse-phase liquid chro-
matography performed on an EASY-nLC 1200 (Thermo
Scientific) coupled to an Orbitrap Q-Exactive HF mass
spectrometer (Thermo Scientific). Elution was carried out
using a binary gradient with buffer A: water and B: 80%
acetonitrile in water, both containing 0.1% formic acid.
Peptide mixtures were separated at 300 nl/min flow rate,
using a 50 cm fused silica emitter (New Objective) packed
in house with ReproSil-Pur C18-AQ, 1.9 μm resin (Dr
Maisch GmbH). Packed emitter was kept at 50 °C by
means of a column oven integrated into the nanoelec-
trospray ion source (Sonation). The gradient used started
at 2% of buffer B (5 min), then increased to 16% over
185min and then to 28% over 30min. The eluting peptide
solutions were electrosprayed into the mass spectrometer
via a nanoelectrospray ion source (Sonation). An Active
Background Ion Reduction Device (ABIRD) was used to
decrease ambient contaminant signal level. Eluted pep-
tides were analysed in the Orbitrap Q-Exactive HF. A full
scan (FT-MS) was acquired at a target value of 3e6 ions
with resolution R= 60,000 over mass range of
375–1500 amu. The top 15 most intense ions were
selected for fragmentation using a maximum injection
time of 50ms or a target value of 5e4 ions.
Protein, MS data analysis
The MS Raw files were processed with MaxQuant soft-
ware14 version 1.5.5.1 and searched with Andromeda
search engine15, querying UniProt16 Homo sapiens (09/07/
2016; 92,939 entries). The database was searched requiring
specificity for trypsin cleavage and allowing maximum two
missed cleavages. Methionine oxidation and N-terminal
acetylation were specified as variable modifications, and
Cysteine carbamidomethylation as fixed modification. The
peptide, protein and site false discovery rate (FDR) was set
to 1%. Protein were quantified according to the label-free
quantification algorithm available in MaxQuant17. Max-
Quant output was further processed using Perseus software
version 1.5.5.318. The common reverse and contaminant
hits (as defined in MaxQuant output) were removed. Only
protein groups identified with at least one unique peptide
were used for the analysis.
Oxygen consumption rate
Cells were plated at 35,000 cells per well in a 96-well XF
cell culture microplate (Seahorse Bioscience). Cells were
equilibrated for 1 h at 37 °C in bicarbonate-free IMDM
media (pH 7.3) with according treatments before any
measurement. OCR and ECAR were measured three
times every 9 min using a XFe96 Analyzer (Seahorse
Bioscience) at a baseline and after addition of each drug.
To assess the mitochondrial respiratory ability, oligomy-
cin (1 μM), CCCP (1 μM), rotenone (1 μM) and antimycin
A (1 μM) were injected subsequently. To assess glycolysis,
oligomycin (1 μM) and 2-Deoxyglucose (50mM) were
added subsequently.
Western blotting
HAP1 WT or SHMT2 KO cells were seeded in 60-mm
dishes and stimulated with 1 mM formate (Sigma-
Aldrich), 10 μM A769662 (Cayman Chemicals) or 1 μM
AICAR (Sigma-Aldrich) as indicated. Cells were washed
twice in ice-cold PBS and lysed in RIPA buffer (Thermo
Scientific) containing cOmplete phosphatase and protease
inhibitors (Sigma-Aldrich). Equal amount of proteins
were separated by electrophoresis on 3–8% 1.0 mm Tris-
Acetate NuPage gels (Thermo Scientific) and transferred
to nitrocellulose using an Invitrogen XCell II Blot Mod-
ule. Membranes were incubated overnight at 4 °C using
the following primary antibodies: ACC phospho-Ser79
(#3661), total ACC (#3676), AMPK phospho-T172
(#2531), total AMPK (#2532) (Cell Signalling Technolo-
gies). Secondary antibodies were donkey anti-mouse
800CW and goat anti-rabbit IgG (H+ L) Alexa Fluor
680 (Li-COR Biosciences and Thermofisher, respectively).
Immunoblots were analysed and protein densities quan-
tified using an Odyssey CLx imager and Image Studio Lite
software (Li-COR Biosciences).
Quantification and statistical analysis
Presented data are derived from three or more inde-
pendent experiments, each with three technical replicates,
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unless specified. The average values for each independent
experiment are indicated by the scatter symbols in the
figures. The exceptions are the protein quantifications by
mass spectrometry and the metabolomics data of the
SHMT2 panel of deficient cell lines, were technical
replicates were used. For two-groups comparisons the
statistical significance was calculated with a Welch’s t test
with two tails and unequal variance. The availability of
one-carbon units was quantified by the index 0 (MFT-
SHMT1), 1 (MFT, SHMT2), 2 (MFT+ 1mM Formate,
SHMT2+ 1mM Formate, WT). The protein changes
were quantified by the slope of the log2 LFQ intensity vs
the one-carbon availability index. The statistical sig-
nificance of the slopes was estimated from 1 million
permutations of the log2 LFQ intensities across the dif-
ferent cell lines/conditions. The enrichment of pathways
for up and down regulated proteins was quantified by the
gene set enrichment test19, using as input the slopes and
the pathway annotations from The Molecular Signatures
Database (MSigDB)20. The association of the remaining
variables with the availability of one-carbon units was
determined using the Spearman rank correlation coeffi-
cient (S) between the variable and the one-carbon avail-
ability index. The statistical significance of S was
estimated from 1 million permutations of the variable
values across the different conditions.
Results
Mathematical model
We analysed a simplified mathematical model where
formate is produced from the mitochondrial one-carbon
metabolism or consumed from the extracellular media
(Fig. 1a, Supplementary text). The produced formate is
released from cells or incorporated into adenine nucleo-
tides. The free pools of adenine nucleotides (AMP, ADP
and ATP) are established by the adenylate kinase equili-
brium, ADP phosphorylation and ATPases activity.
Numerical simulations of kinetic models of glycolysis
and oxidative phosphorylation indicate that the rates of
ADP phosphorylation by glycolysis and oxidative phos-
phorylation follow effective Michaelis–Menten relation-
ships with respect to the concentration of ADP (Fig. 1b,
c). This observation is quite surprising given that both
pathways have multiple reactions, with steps of ATP
hydrolysis, ADP phosphorylation and oxidation/reduction
reactions. These effective Michaelis–Menten models link
energy and purine metabolism.
Next, we conducted numerical simulations of the full
model of formate, purine and energy metabolism. The
numerical simulations predict that, with increasing the
rate of endogenous formate production, there is an
increase in the concentration of formate and adenine
nucleotides and the rates of glycolysis, oxidative phos-
phorylation and proliferation (Fig. 1d–j, black line).
Furthermore, cells start releasing formate when the rate of
serine catabolism to formate reaches the threshold rate
defined by the purine synthesis rate (Fig. 1k, black line).
One-carbon units can be derived from extracellular
formate and cytosolic metabolism as well. The effect of
adding exogenous formate is to displace the prediction
lines to the left (Fig. 1d–k, red line). To simulate the
contribution of the cytosolic pathway to one-carbon unit
production we added an additional flux of 10-formyl-
tetrahydrofolate production, setting its rate to 50% the
maximum activity of 10-formyl-tetrahydrofolate synthe-
tase. The effect of the cytosolic pathway is similar to what
observed for exogenous formate, it displaces the predic-
tion lines to the left (Fig. 1d–k, cyan line).
In these simulations we assumed that the cell energy
demand is coupled to an effective ATP consuming reac-
tion with a Michalis-Menten dependency with the ATP
levels. This assumption was motivated by the fact that
some synthetases, like mammalian carbamoyl-phosphate
synthetase (CAD), have a half-saturation constant on the
mM ATP range21. An alternative hypothesis is that the
proliferation rate is limited by the availability of deox-
ynucleotides, which in the case of adenines are derived
from ADP. We have repeated the model simulations
assuming that the proliferation rate follows a
Michaelis–Menten relationship with the ADP levels and
the outcome is the same (Fig. S1, red line). We have also
repeated the simulations assuming a constant prolifera-
tion rate. In this case the transition from low to high
purines is even more pronounced (Fig. S1, cyan line).
In vitro model
To validate the theoretical predictions, we selected a
panel of haploid HAP1 cell lines engineered for single
knockout of SHMT2 or the mitochondrial folate trans-
porter (MFT) and double knockout of MFT and cytosolic
serine hydroxymethyltransferase (SHMT1) (Fig. 2a). The
intracellular formate levels are the lowest in the MFT-
SHMT1 double knockout cell line, intermediate in the
SHMT2 single knockout cell line and maximum in the
WT parental cell line (Fig. 2b). Furthermore, supple-
mentation of sodium formate at a concentration of 1 mM
increases the intracellular formate levels of the MFT-
SHMT1 and SHMT2 cell lines to values similar to what is
observed in the WT cells (Fig. 2b). Based on this data, we
assigned the one-carbon units availability index 0 to
MFT-SHMT1, 1 to MFT and SHMT2, and 2 to MFT+
1mM Formate, SHMT2+ 1mM Formate and WT.
We first characterized the proteome of these cell lines
using mass spectrometry (Table S1). To identify protein
level changes associated with the availability of one-
carbon units we calculated the slope between the protein
levels and the one-carbon availability index. We observed
a significant increase in the levels of proteins belonging to
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the minichromosome maintenance protein complex
(MCM) and of ribosomal proteins (Table S2). The
increase in ribosomal proteins results in a gradual
increase of the total ribosomal protein mass (Fig. 2c). In
contrast, we observed just a trend towards decrease in the
levels of mitochondrial and vacuole proteins (Table S2).
The total proteome mass associated with proteins with
annotated mitochondrial localization22 is approximately
constant across the different cell lines (Fig. 2d). We did
not observe any significant enrichment of genes asso-
ciated with metabolic pathways, except for a trend of
reduced levels of glycolysis and TCA proteins (Table S3).
The total proteome mass associated with proteins in the
KEGG glycolysis pathway is approximately constant
across the different cell lines (Fig. 2e).
Next we performed a metabolic characterization. As
predicted by the model, the levels of intracellular AMP,
ADP and ATP increase from the knockout cell lines to the
WT cell lines and when the knockout cell lines are sup-
plemented with formate (Fig. 2f–h). In agreement with
the behaviour suggested by the computational model of
glycolysis (Fig. 1b), the rate of lactate release (a surrogate
of glycolysis) approximately follows a Michaelis–Menten
dependency with the intracellular ADP levels (Fig. 2i). In
the case of oxidative phosphorylation the data deviates
from a Michaelis–Menten law suggested by the computer
simulations of mitochondrial oxidative phosphorylation
(Fig. 2j). Finally, as assumed in the mathematical model,
the proliferation rate approximately follows a
Michaelis–Menten relationship with the intracellular
ATP levels (Fig. 2k).
To test the metabolic switch beyond the HAP1 back-
ground, we generated a panel of SHMT2 deficient cell
lines for the colorectal cancer cell line HCT116 and breast
cancer cell lines MDA-MB-231, SKB3, T47D and MDA-
MB-468. The parental cell lines exhibit formate overflow
Fig. 1 Theoretical model. a Graphical model linking formate and energy metabolism, including the contribution of the mitochondrial (Mito 1C) and
cytosolic (Cyto 1C) one-carbon metabolism and extracellular formate (Formate). b, c Scatter plots of the simulated ADP phsophorylation rate by
glycolysis and oxidative phosphorylation as a function of the ADP concentration. Each point represents a set of values for the different cofactors
(ADP, ATP, NAD+, NADH). The line represents a fit to the Michaelis–Menten equation. d–k Model predictions with increasing the rate of formate
production, with the addition of 0.02 mM extracellular formate (black), 1 mM extracellular formate (red) or 0.02 mM extracellular formate plus
cytosolic one-carbon production (cyan). The grey background highlights the formate overflow state.
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and the phenotype is lost upon genetic inactivation of
SHMT2 (Fig. S2a). In the HCT116 and MDA-MB-231
background the SHMT2 deficiency causes a reduction in
the adenine nucleotide levels (Fig. S2b–d), in agreement
with our theoretical and HAP1 genetic models. However,
this is not the case in the SKB3, T47D and MDA-MB-468
cell lines. Therefore, there are additional factors that
modulate the control of the adenine nucleotide pools by
mitochondrial formate production.
Formate increases AICAR and reduces AMPK activity
To uncover metabolic changes not anticipated by the
mathematical model, we extended the correlation analysis
between the intracellular metabolites and the one-carbon
availability index (Table S4). We noted a significant
negative association between the one-carbon availability
index and the levels of purine precursors glycinamide
ribonucleotide (GAR, p= 10−6) and 5-aminoimidazole-4-
carboxamide ribonucleotide (AICAR, p= 5.4 × 10−4)
(Fig. 2f vs Fig. 3a, b). The elevation of AICAR in cells
deficient of mitochondrial one-carbon metabolism has
been observed in other cell lines5,23. We also observe an
elevation of AICAR in our panel of SHMT2 deficient cell
lines (Fig. S1e). The effect being more pronounced in
those cell lines where the SHMT2 deficiency is associated
with a depletion of adenine nucleotides (Fig. S2b–d).
Given that both AICAR and AMP are AMPK activa-
tors24, the formate-dependent decrease of AICAR while
Fig. 2 In vitro genetic model. a One-carbon metabolism pathway highlighting genes that were genetically inactivated (ovals). b Intracellular
formate levels in the indicated cell lines. c–e Total protein mass associated with the indicated pathways. f–h Intracellular adenine metabolite levels.
i–k Scatter plots of metabolic rates as a function of intracellular adenine nucleotide levels. The line represents a fit to a Michaelis–Menten equation.
Notations: +F indicates 1 mM formate supplementation. Symbols represent independent experiments. Error bars represent the standard deviation.
Oizel et al. Cell Death and Disease          (2020) 11:310 Page 6 of 14
Official journal of the Cell Death Differentiation Association
Fig. 3 Formate incresses AICAR and suppresses the AMPK activity. a–h Metabolic changes associated with increasing the availability of one-
carbon units. Only metabolites relevant for the discussion are reported. The full list of metabolites analysed can be found in Table S4. i Immunoblots
of AMPK, phospho-AMPK, ACC and phospho-ACC (one representative experiment from three). j, k Quantification of immunoblots at the 24-h time
point. Notations: +F denote 1 mM formate supplementation. Symbols represent independent experiments. Error bars represent the standard
deviation. Solid bars indicate significant change (p < 0.05) and dashed bars trend (p < 0.1) relative to untreated cells of the same genetic background
(two-sided, unequal variance, T test).
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increasing AMP results in conflicting signals to AMPK.
To determine which signal dominates, we quantified the
level of AMPK phosphorylation using phosphoantibodies
specific for pAMPK-Thr172, a canonical AMPK site that
is phosphorylated under energy stress24. We observed
higher levels of pAMPK-Thr172/AMPK in SHMT2 defi-
cient cells relative to WT cells (Fig. 3i, j). The noted
changes in SHMT2 deficient cells are more pronounced
than what was observed when treating WT cells with the
AMPK activators acadesine (1 mM) or A769662 (10 μM).
Finally, supplementation with 1 mM formate reduces
pAMPK-Thr172/AMPK in SHMT2 deficient cells to
levels between untreated SHMT2 deficient cells and
WT cells, without much of an effect on WT cells.
Activated AMPK phosphorylates multiple proteins,
including acetyl-CoA carboxylase (ACC) at serine 79
(Ser79)24. The changes of pACC-Ser79/ACC in SHMT2
deficient cells are quite similar to those observed for
pAMPK-Thr172 /AMPK (Fig. 3j, k, T2 genetic back-
ground), indicating that in SHMT2 cells the level of ACC
phosphorylation is either regulated by AMPK or by an
upstream kinase targeting both AMPK and ACC. In con-
trast, the pattern of ACC phosphorylation in WT cells is
different from that of AMPK phosphorylation. A clear
Fig. 4 Evidence for an ATP-dependent increase in orotate. a–c Changes in AICAR, orotate and ATP following supplementation of 50 μM of purine
metabolites to SHMT2 (T2) deficient and WT cells. d Scatter plot of orotate versus ATP. e Schematic model of orotate flux balance. f Fit of the
theoretical model (line) to the scatter plot of orotate versus ATP. Notations: Symbols represent independent experiments. Error bars represent the
standard deviation. Solid bars indicate significant change relative to untreated cells of the same genetic background (p < 0.05, two-sided, unequal
variance, T test).
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example is the formate-dependent reduction of ACC
phosphorylation in WT cells with no significant changes in
AMPK phosphorylation, suggesting an AMPK-independent
mechanism (Fig. 3j, k, WT genetic background).
Taken together these data indicate that AMPK activity
is repressed by formate, either produced endogenously by
mitochondrial one-carbon metabolism or supplemented
exogenously.
Formate increases pyrimidine nucleotides
The correlation analysis also revealed a positive asso-
ciation between the one-carbon availability and the levels
of pyrimidine precursors dehydro-orotate and orotate and
pyrimidines UMP and deoxythymidine triphosphate
(dTTP) (Fig. 3e–h). Glutamine and aspartate, two pre-
cursors of pyrimidine synthesis, were rather depleted with
increasing the availability of one-carbon units (Fig. 3c, d),
Fig. 5 In vitro model of formate supplementation. a–j Metabolic changes associated with formate supplementation to the MFT-SHMT1 cell line,
using twofold dilutions: 1 mM (0), 0.5 mM (−1), 0.25 mM (−2), 0.125 mM (−3), 0.0625 mM (−4), 0.031255) mM (−5), 0.015625mM (−6), 0.0078125mM
(−7) and 0.00390625 mM (−8). Notations: Symbols represent independent experiments. Error bars represent the standard deviation.
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excluding them as the cause of increased dehydro-orotate
and orotate levels.
Acadesine, which is converted to intracellular AICAR
after uptake and phosphorylation, was reported to
increase orotate levels25. To follow this lead we performed
purine nucleotides supplementation experiments and
quantified intracellular metabolites. We found no asso-
ciation between endogenous AICAR and orotate levels
(Fig. 4a, b). Since the first step of pyrimidine synthesis is
catalysed by the ATP-dependent activity of carbamoyl-
phosphate synthetase, we hypothesized that the observed
changes in orotate levels are determined by changes in
ATP levels. Indeed, there is a better association between
the intracellular levels of orotate and ATP, than between
orotate and AICAR (Fig. 4a–c). This association is more
evident in a scatter plot of orotate versus ATP levels (Fig.
4d). These data are explained by a theoretical model of
orotate metabolism (Fig. 4e, Supplementary Text). When
the maximum orotate production rate exceeds that of
turnover the model predicts a steep increase in orotate
levels as the levels of ATP approach a limiting value, as
observed (Fig. 4f).
The changes in dehydro-orotate and orotate levels are
recapitulated in the panel of SHMT2 deficient cell lines
(Fig. S2f, g). In the HCT116, MDA-MB-231 and SKB3
backgrounds the SHMT2 deficiency causes a drop in ATP
levels that is accompanied by a drop in dehydro-orotate
and orotate levels. In contrast, in the MDA-MB-468 and
T47D cell lines, where the SHMT2 deficiency does not
decrease the ATP levels, there are no appreciable changes
in the dehydro-orotate and orotate levels.
Formate supplementation
To provide additional evidence, we have titrated the
amount of formate supplemented to the MFT-SHMT1
deficient cell line and quantified intracellular metabolites
(Fig. 5a–j). Formate supplementation induced a dramatic
difference in metabolite concentrations at a formate
concentration of about 100 μM. Below this concentration
the adenine nucleotide levels are low and approximately
constant (Fig. 5a–c), increasing twofold or higher at for-
mate concentrations of 500 μM or 1mM. At low sup-
plemented formate concentration (below 100 μM),
AICAR increases with increasing the concentration of
supplemented formate, then drops down to undetectable
levels at the formate concentrations of 500 μM or 1mM
(Fig. 5d). Dehydro-orotate and orotate also exhibit a sharp
increase above a supplemented formate concentration of
100 μM (Fig. 5e, f). Finally, there is a gradual decrease of
the intracellular glucose concentration with increased
concentration of supplemented formate (Fig. 5g). In
contrast, the intracellular lactate levels exhibit a switch-
like behaviour, with a sharp increase above a supple-
mented formate concentration of 100 μM (Fig. 5h).
The switch-like increase in lactate levels can be explained
by the association between the rate of glycolysis and the
ADP levels and the switch-like increase of ADP levels
induced by formate (Fig. 5b).
To search for additional metabolites that could be
modulated by ATP levels we calculated the spearman
correlation coefficient between ATP and intracellular
metabolite levels (Table S6). As anticipated by the results
described above, the top associations included a positive
correlation with purines and pyrimidines and a negative
association with the purine synthesis intermediate meta-
bolites (GAR, SAICAR, AICAR). We also noted a positive
correlation between ATP levels and the levels of argini-
nosuccinate (Fig. 5i). Argininosuccinate synthetase is an
ATP driven enzyme that, as carbamoyl-phosphate syn-
thetase, exhibits cooperativity for ATP26. A kinetic study
of yeast argininosuccinate synthetase indicates that the
enzyme kinetics is characterized by a sigmoidal depen-
dency with respect to the concentration of ATP, with a
Hill coefficient of 2. Therefore, similarly to orotate, the
formate-dependent increase of argininosuccinate can be
explained by the formate-dependent increase of ATP and
the ATP-dependent activity of arginonosuccinate syn-
thetase. We also noted that malate is increased following
formate supplementation (Fig. 5j). These changes are
consistent with the fact that fumarate is a by-product of
both argininosuccinate turnover and purine synthesis and
that fumarate is converted to malate by fumarate hydra-
tase. The formate-dependent induction of argininosucci-
nate and malate is not recapitulated when comparing the
panel of SHMT2 deficient cell lines with their parental
cell lines (Fig. S2h, i).
Pharmacological inhibition
Going in the opposite direction, we tested the formate-
dependent metabolic switch in the context of pharma-
cological inhibition using the serine hydro-
xymethyltransfarece inhibitor SHIN127. The data are an
almost specular image of what is observed in the formate
supplementation experiments (Fig. S3a–j). From this data
we can conclude that inhibition of serine hydro-
xymethyltransfarase activity causes a systemic inhibition
of cell metabolism that is mediated by the formate-
dependent metabolic switch uncovered here.
In vivo validation in mouse models of cancer
To provide an in vivo validation we analysed differ-
ences between tumours and the adjacent normal tissues
(Fig. 6a). As previously shown, the relative rate of serine
catabolism to formate is increased in the transformed
tissues relative to the adjacent normal tissues, in the
APCmin/+ mouse model of colorectal adenomas and the
PyMT model of breast adenocarcinoma7 (Fig. 6b). We
have also shown that the transformed tissues have a high
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NAD+/(NAD+ +NADH) ratio that is similar than the
adjacent normal tissue7 (Fig. 6c). The latter suggests that
the tumour tissues have a similar redox status than the
adjacent normal tissue. We have re-analysed the LC-MS
data to extract the quantifications of relevant metabo-
lites. The fraction of de novo synthesized purines, a
surrogate of the purine synthesis rate, is significantly
higher in the tumour tissues than in the adjacent normal
tissues (Fig. 6d). The levels of ADP are increased in the
transformed tissues relative to the adjacent normal tis-
sues (Fig. 6e, trend in the APCmin/+ model and sig-
nificant in the PyMT model). Furthermore, the levels of
lactate are increased in the transformed tissues relative
to the adjacent normal tissues (Fig. 6f, trend in the
APCmin/+ and significant in PyMT models). Although
these associations are not causal proof, they are con-
sistent with our mechanistic model of increased formate
production purine synthesis, ADP levels and lactate
levels. In agreement with the in vitro models, there is
also a significant increase in the levels of orotate in the
tumour tissue relative to the adjacent normal tissue
(Fig. 6g).
The AICAR levels are increased in the tumour tissue
relative to the normal tissue (Fig. 6h). Based on our
in vitro data this change would be the expectation if the
transition happens from low to intermediate formate
availability. In the genetic in vitro model, AICAR increa-
ses from the MFT-SHMT1 deficient to the SHMT2 or
MFT deficient cell lines, then dropping in the WT cells
(Fig. 3b). In the in vitro model of formate supplementa-
tion, AICAR increases when the MFT-SHMT1 deficient
cells are supplemented with formate up to a concentra-
tion 100 μM, then dropping at 1 mM supplemented for-
mate (Fig. 5d). We note that aspartate and glutamine,
which are required as cofactors both upstream and
downstream of AICAR, exhibit significantly higher levels
in the tumour tissue relative to the normal tissue,
while glycine is not significantly different (Fig. S4a–c).
Fig. 6 In vivo validation in cancer models. a Schematic representation of the normal and tumour tissue composition. b–j Metabolic features of
transformed (T) and adjacent normal (N) tissues of the APCmin/+ and PyMT mouse models of colorectal adenomas and breast adenocarcinomas.
Notations: Each symbol represents a different mouse. Error bars indicate standard deviation. k–o Gene signature enrichment scores (k) and metabolic
features (l–o) of human colorectal tumours and adjacent normal tissue. Notations: The error bars indicate 90% confidence intervals, the boxes 50%
confidence intervals and horizontal line the median. Symbols outside the boxes represent individual samples. Green solid or dashed bars indicate
significance increase (p < 0.05) or trend (p < 0.1) in transformed tissue relative to normal (two-sided, unequal variance, T test).
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This increase in aspartate and glutamine levels in the
tumour tissue may also contribute to the increased
AICAR levels.
Finally, the levels of argininosuccinate and malate are
significantly increased in tumour tissue of the PyMT
model, but not in the APCmin/+ model (Fig. 6i, j). A
similar discrepancy was observed in our in vitro models.
The HAP1 cells manifest a SHMT2-dependent elevation
of the intracellular argininosuccinate levels, but this is not
the case for the other cell lines tested. This discrepancy is
anticipated by our theoretical analysis (Supplementary
Text), depending on the relative maximum activity of
argininosuccinate synthesis and turnover. In turn, the lack
of significant changes of malate in the APCmin/+ model
could be the consequence of lack of changes in argini-
nosuccinate, which is turned over to fumarate and sub-
sequently to malate (Fig. 5, pathway inset).
In vivo validation in human colorectal cancer
Recently Satoh et al. have shown that colorectal cancers
are characterized by a global metabolic reprogramming
induced by Myc28. Since MYC activates the transcription
of mitochondrial one-carbon metabolism genes3,29, we
hypothesized that MYC-driven colorectal cancers should
manifest the formate-dependent metabolic switch. To test
this hypothesis, we first performed a gene signature ana-
lysis using the reported gene expression array data for 41
colorectal tumour samples and 39 normal colorectal
samples28. Using gene set enrichment analysis19 we
quantified the enrichment of relevant gene signatures in
the different samples (gene signature enrichment score).
There are no significant differences in the enrichment
scores for gene signatures of oxidative phosphorylation,
HIF1α targets and glycolysis (Fig. 6k). In contrast, there is
a significant increase of the mitochondrial one-carbon
metabolism enrichment score signature in the tumour
relative to the normal samples (Fig. 6k). The latter is also
consistent with an increase of the enrichment score of a
MYC targets signature in the tumour relative to the
normal colorectal samples (Fig. 6k).
Next, we analysed reported metabolomic data from 275
normal and 275 tumour samples28. The tumour tissues
exhibit a high NAD+/(NAD++NADH) ratio that is not
significantly different from that of the normal tissues
Fig. 7 In vivo formate bolus. a Experiment design. A bolus of 13C-formate (For) or vehicle (Ctrl) was injected intraperitoneally to C57BL/6J mice.
b–l Plasma metabolite levels after administration of the formate bolus or vehicle. Samples were collected from different mice at the indicated time
intervals after the bolus injection. Notation: Each symbol represents a different mouse. Error bars indicate standard deviation. Solid bars indicate
significant change or trend relative to control (p < 0.05 and p < 0.1, two-sided, unequal variance, T test).
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(Fig. 6l). That together with the HIF targets signature
evidence suggest that the MYC-driven colorectal tumours
are of oxidative nature and that their oxidative status is
not significantly different from that of normal tissues. In
contrast, there is a significant increase in the levels of
ADP, lactate and malate in the tumour samples relative to
the normal tissues (Fig. 6m–o). Although these associa-
tions are not causal prove, they are consistent with what
predicted by the formate-dependent metabolic switch.
In vivo validation following a formate bolus
To provide a direct in vivo validation of the formate-
dependent metabolic switch we intraperitoneally admi-
nistered a bolus of formate or vehicle to C57BL/6J mice
fasted overnight (Fig. 7a). Different mice were used to
collect plasma samples at 1, 2 and 4 h after the bolus
injection. Plasma formate reached between 500 μM to
1mM levels 1 h after the bolus injection, going down to
μM levels 2 h after the bolus injection (Fig. 7b). At 1 h
there is a significant depletion of plasma glycine (Fig. 7c)
and a significant increase of plasma serine (Fig. 7d), which
are consistent with the reverse activity of liver serine
hydroxymethyltransferase and the administration of
excess formate.
At 1 h, when the observed formate concentration was
highest, there is a significant depletion of plasma glucose
(Fig. 7e) and a non-significant trend towards increased
plasma lactate (Fig. 7f). These changes are consistent with
the formate-dependent induction of glycolysis. The lack of
significant changes in plasma lactate could be due to
lactate oxidation at the tissues where glucose metabolism
is increased.
As observed in our in vitro models, the formate bolus
induces a significant increase of plasma orotate and
malate levels at the 1-h time point (Fig. 7g, h). In the case
of orotate the significant increase persists 4 h after bolus
injection. Since all other significant changes are absent at
the 2- and 4-h time points, the simplest explanation is
that the orotate turnover is slow, taking a long time to
come back to control levels. In contrast, the levels of
argininosuccinate does not change significantly at any
time point (Fig. 7i). Finally, there are no significant
changes in the levels of other amino acids implicated in
purine, pyrimidine and argininosuccinate metabolism
(aspartate, arginine and glutamine, Fig. 7j–l).
Therefore, a bolus of formate causes changes at the level
of whole-body metabolism that are similar to what
observed in our in vitro models.
Discussion
Our analysis indicates that formate induces a metabolic
switch in purine, pyrimidine and energy metabolism. The
increase in purine nucleotides was expected given that
formate is a precursor of de novo purine synthesis1,2. The
formate-dependent induction of the increase in the pyr-
imidine precursor orotate can be explained, at theoretical
level, by the ATP-dependent activity of carbamoyl-
phosphate synthetase. Finally, provided that the levels of
glycolytic enzymes remain constant, the formate-
dependent increase in ADP levels is associated with an
increase in the rate of glycolysis and intracellular lactate
levels.
In contrast, formate deficiency causes a dramatic
increase in AICAR levels and induces AMPK activity. The
activation of AMPK in formate deficient cells is likely
mediated by the dramatic increase in AICAR levels, the
reduction in purine levels, or a combination of both. A
similar phenotype is achieved with purine synthesis
inhibitors. This has been shown for antifolates such as
pemetrexed and methotrexate30–33 and for a dimerization
inhibitor of AICAR formyltransferase as well34.
Further work is required to determine the relevance of
the formate-dependent metabolic switch in the context of
embryonic development, cancer and immune system
metabolism. Homozygous deletion of MTHFD1L, whose
gene product contribute to the mitochondria formate
production, is embryonic lethal and it can be rescued by
formate supplementation35. The formate-dependent
metabolic switch could explain the requirement of mito-
chondrial one-carbon metabolism during embryonic
development. There is also evidence for a partial depen-
dency on mitochondrial one-carbon metabolism for
cancer growth. Deprivation of serine in the diet delays
tumour growth in genetic mouse models of cancer36.
Suppression of mitochondrial one-carbon metabolism
genes reduces growth in xenograft models of cancer5,37.
Further work is required to investigate whether the
reduction in cancer growth is determined by a reduction
in nucleotide synthesis, energy metabolism or a con-
tribution of both. Mitochondrial serine catabolism to
formate is also essential for T-cell expansion38,39. Defec-
tive respiration and mitochondrial one-carbon metabo-
lism contribute to a reduction in T-cell activation during
aging of mice40. This evidence together with the long
known role of aerobic glycolysis in T-cell activation41,42
suggests a role for the proposed formate link between
respiration and glycolysis during T-cells activation.
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